Cargando…

Serotonin Impairment in CSF of PD Patients, without an Apparent Clinical Counterpart

In Parkinson's disease (PD), several studies have detected an impaired serotonin (5-HT) pathway, likely affecting both motor and non-motor domains. However, the precise impact of 5-HT impairment is far from established. Here, we have used a HPLC chromatographic method, in a homogenous cohort (n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olivola, Enrica, Pierantozzi, Mariangela, Imbriani, Paola, Liguori, Claudio, Stampanoni Bassi, Mario, Conti, Marco, D′Angelo, Vincenza, Mercuri, Nicola Biagio, Stefani, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103775/ https://www.ncbi.nlm.nih.gov/pubmed/25036938 http://dx.doi.org/10.1371/journal.pone.0101763

Ejemplares similares

Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson’s Disease
por: Liguori, Claudio, et al.
Publicado: (2015)

Catecholamine-Based Treatment in AD Patients: Expectations and Delusions
por: Stefani, Alessandro, et al.
Publicado: (2015)

The Serendipity Case of the Pedunculopontine Nucleus Low-Frequency Brain Stimulation: Chasing a Gait Response, Finding Sleep, and Cognition Improvement
por: Stefani, Alessandro, et al.
Publicado: (2013)

Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence
por: Liguori, Claudio, et al.
Publicado: (2022)

Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations
por: Fernandes, Mariana, et al.
Publicado: (2021)

When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression
por: Liguori, Claudio, et al.
Publicado: (2018)

Dyspnea perception and neurological symptoms in non-severe COVID-19 patients
por: Ora, Josuel, et al.
Publicado: (2020)

Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study
por: De Masi, Claudia, et al.
Publicado: (2022)

Both Motor and Non-Motor Fluctuations Matter in the Clinical Management of Patients with Parkinson’s Disease: An Exploratory Study
por: Carpi, Matteo, et al.
Publicado: (2023)

Not just a Snapshot: An Italian Longitudinal Evaluation of Stability of Gut Microbiota Findings in Parkinson’s Disease
por: Cerroni, Rocco, et al.
Publicado: (2022)

Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy
por: Schirinzi, Tommaso, et al.
Publicado: (2020)

Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort
por: Bovenzi, Roberta, et al.
Publicado: (2023)

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism
por: Cerroni, Rocco, et al.
Publicado: (2020)

STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson’s Disease
por: Conti, Matteo, et al.
Publicado: (2022)

Adult-onset sporadic chorea: real-world data from a single-centre retrospective study
por: Bovenzi, Roberta, et al.
Publicado: (2021)

Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID‐19 Lockdown
por: Schirinzi, Tommaso, et al.
Publicado: (2020)

Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

Exploring the Association Linking Head Position and Sleep Architecture to Motor Impairment in Parkinson’s Disease: An Exploratory Study
por: Gnarra, Oriella, et al.
Publicado: (2023)

Neurotrophins as Therapeutic Agents for Parkinson’s Disease; New Chances From Focused Ultrasound?
por: Stefani, Alessandro, et al.
Publicado: (2022)

Brain Functional Connectivity in de novo Parkinson's Disease Patients Based on Clinical EEG
por: Conti, Matteo, et al.
Publicado: (2022)

Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease
por: Sisto, Renata, et al.
Publicado: (2020)

Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence
por: Schirinzi, Tommaso, et al.
Publicado: (2019)

Restless Legs Syndrome and Poliomyelitis: New Evidences of an Old Observation?
por: Romigi, Andrea, et al.
Publicado: (2015)

Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease
por: Assogna, Francesca, et al.
Publicado: (2021)

Association between hearing sensitivity and dopamine transporter availability in Parkinson’s disease
por: Garasto, Elena, et al.
Publicado: (2023)

Depressive and anxiety symptoms in patients with SARS-CoV2 infection
por: Liguori, Claudio, et al.
Publicado: (2021)

Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
por: Liguori, Claudio, et al.
Publicado: (2020)

No apparent effect of naproxen on CSF markers of innate immune activation
por: Meyer, Pierre‐François, et al.
Publicado: (2019)

Commentary: Sleep Changes without Medial Temporal Lobe or Brain Cortical Changes in Community-Dwelling Individuals with Subjective Cognitive Decline
por: Liguori, Claudio, et al.
Publicado: (2017)

The Importance of Diagnosing and the Clinical Potential of Treating Obstructive Sleep Apnea to Delay Mild Cognitive Impairment and Alzheimer’s Disease: A Special Focus on Cognitive Performance
por: Fernandes, Mariana, et al.
Publicado: (2021)

Ageing of the human metaorganism: the microbial counterpart
por: Biagi, Elena, et al.
Publicado: (2011)

Psychiatric profile of motor subtypes of de novo drug‐naïve Parkinson's disease patients
por: Assogna, Francesca, et al.
Publicado: (2018)

(18)F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment
por: Fernandes, Mariana, et al.
Publicado: (2022)

CSF contamination contributes to apparent microstructural alterations in mild cognitive impairment
por: Berlot, Rok, et al.
Publicado: (2014)

Counterparts: Chap. I
Publicado: (1887)

Counterparts: Chap. III
Publicado: (1887)

Counterparts: Chap. II
Publicado: (1887)

Pluralities, counterparts, and groups
por: Wilhelm, Isaac
Publicado: (2022)

Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine
por: Liguori, Claudio, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hj2n6k2ch86diicmpsv8njsjug